To date, many studies have explored curcumin as an anti-inflammatory agent based on cytokine dosage and immune cell population in sepsis; however, there are no reports of its in vivo effect on the mTOR pathway in any pathology, especially in sepsis [29]. Here, MTOR is linked to Sepsis.